<DOC>
	<DOCNO>NCT00311077</DOCNO>
	<brief_summary>Primary objective - To investigate pharmacodynamic pharmacokinetic parameter s.c. administration two different dos ( low dose , 0.2 IU/kg high dose , 0.4 IU/kg ) insulin glulisine across healthy subject 4 different BMI-classes ( lean , overweight , moderately obese , severely obese ) , use euglycemic clamp technique Biostatorâ„¢ . Secondary objective - To investigate pharmacodynamic pharmacokinetic property subcutaneous administration insulin glulisine comparison insulin lispro investigate safety tolerability subcutaneous administration insulin glulisine comparison insulin lispro .</brief_summary>
	<brief_title>Insulin Glulisine Healthy Lean Obese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin glulisine</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Inclusion criterion : Normal HbA1c Women either postmenopausal , surgically sterilize , pregnant use adequate contraception . Exclusion criterion : Systemic concomitant medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>